Posted On: 12/02/2014 5:59:57 PM
Post# of 30066
Re: Ea$y Money #12256
Yes, he really did an impressive job presenting a lot info quickly. And his explanation of lympro and cell cycle dysregulation has improved - it's easier to understand now compared to previous presentations.
Interesting that it wasn't until May that amarantus became really interested in acquiring ESS - GC said that the fda removed the clinical hold on ESS in May so figure ambs took up to 7 months to negotiate this agreement.
I like GC's value investing approach re: acquiring distressed drugs and diagnostics like lympro and ESS. It reminds me of Warren Buffett's investing philosophy and that's sort of worked out okay for Buffett.
Interesting that it wasn't until May that amarantus became really interested in acquiring ESS - GC said that the fda removed the clinical hold on ESS in May so figure ambs took up to 7 months to negotiate this agreement.
I like GC's value investing approach re: acquiring distressed drugs and diagnostics like lympro and ESS. It reminds me of Warren Buffett's investing philosophy and that's sort of worked out okay for Buffett.
(0)
(0)
